Brand unveiling: While debuting its new brand at SLAS for the first time, Revvity presents its continued commitment to expanding the boundaries of human potential through science. The transformed ...
Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held in Boston from February 3-7 in ...
WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. and Element Biosciences, Inc., a developer of the AVITI™ System, an innovative and emerging genomic sequencing platform, today announced a ...
As nucleic acid–based therapeutics evolve and mature, so too must the analytical tools that are designed to characterize them. New microfluidic capillary electrophoresis (CE) methods that are designed ...
Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays.
Hosted on MSN
Revvity earnings: What to look for from RVTY
Life sciences company Revvity (NYSE:RVTY) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. Revvity beat analysts’ revenue expectations last quarter, reporting ...
Revvity’s Signals platform, featuring ChemDraw, aims to drive significant growth. New products like Xynthetica and LabGistics are set to enhance AI capabilities. The company maintains a cautious ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held ...
Next generation sequencing workflow with research use only components from both companies is designed to provide flexibility, time and cost savings on sample-to-answer solutions Neonatal research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results